The response to re-emergence of yellow fever in Nigeria, 2017.
Adolescent
Adult
Aedes
/ virology
Africa
Animals
Child
Child, Preschool
Communicable Diseases, Emerging
/ epidemiology
Disease Outbreaks
Female
Humans
Male
Middle Aged
Mosquito Vectors
Nigeria
/ epidemiology
Risk Factors
Yellow Fever
/ epidemiology
Yellow Fever Vaccine
/ administration & dosage
Yellow fever virus
/ immunology
Kwara state-Nigeria
Re-emergence
Response
Yellow fever
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
25
02
2019
revised:
23
12
2019
accepted:
24
12
2019
pubmed:
15
1
2020
medline:
19
3
2020
entrez:
15
1
2020
Statut:
ppublish
Résumé
Yellow fever (YF) is an acute viral hemorrhagic disease caused by the YF virus (arbovirus) which continues to cause severe morbidity and mortality in Africa. A case of YF was confirmed in Nigeria on the 12th of September 2017, 21 years after the last confirmed case. The patient belongs to a nomadic population with a history of low YF vaccination uptake, in the Ifelodun Local Government Area (LGA) of Kwara State, Nigeria. An active case search in Ifelodun and its five contiguous LGAs led to the listing of 55 additional suspect cases of YF within the period of the outbreak investigation between September 18 to October 6, 2017. The median age of cases was 15 years, and 54.4% were males. Of these, blood samples were collected from 30 cases; nine tested positive in laboratories in Nigeria and six were confirmed positive for YF by the WHO reference laboratory in the region; Institut Pasteur, Dakar. A rapid YF vaccination coverage assessment was carried out, resulting in a coverage of 46% in the LGAs, with 25% of cases able to produce their vaccination cards. All stages of the yellow fever vector, Aedes mosquito were identified in the area, with high larval indices (House and Breteau) observed. In response to the outbreak, YF surveillance was intensified across all States in Nigeria, as well as reactive vaccination and social mobilisation campaigns carried out in the affected LGAs in Kwara State. A state-wide YF preventive campaign was also initiated.
Identifiants
pubmed: 31935537
pii: S1201-9712(19)30507-7
doi: 10.1016/j.ijid.2019.12.034
pii:
doi:
Substances chimiques
Yellow Fever Vaccine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
189-196Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.